As of 3:56pm ET
| -0.145 / -2.08%|
The 9 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 17.00 and a low estimate of 5.00. The median estimate represents a +46.31% increase from the last price of 6.84.
The current consensus among 9 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.